Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Bell Global Emerging Companies Fund

Bell Direct
August 23, 2019

June Market Overview

Julia Lee
July 11, 2019

May Market Overview

Julia Lee
May 31, 2019

April Market Overview

Julia Lee
April 29, 2019

Investing in ETFs

Bell Direct
April 17, 2019

March Market Overview

Julia Lee
March 28, 2019

Investing in Alternatives

Julia Lee
March 1, 2019

Margin Lending video

Bell Direct
February 28, 2019

February Market Overview

Julia Lee
February 27, 2019

Market Update

Julia Lee
February 19, 2019

APN Asian REIT Fund

Bell Direct
January 24, 2019